Klivira
Request demo

Aetna Tezspire Prior Authorization: Process, Criteria, and Automation

Mastering Aetna Tezspire prior authorization is critical for ensuring timely patient access to this important biologic therapy for severe asthma. Klivira provides the automation and connectivity to streamline this complex process.

Revenue cycle directors and prior authorization coordinators face significant administrative burden managing specialty drug PAs, especially for high-volume biologics like Tezspire. Understanding Aetna's specific requirements, submission pathways, and policy nuances is essential to minimize delays and denials, impacting both patient care and financial outcomes.

Understanding Aetna Tezspire Prior Authorization Requirements

Tezspire (tezepelumab) is a targeted biologic therapy indicated for the treatment of severe asthma. As a high-cost specialty medication, it consistently requires prior authorization across Aetna's commercial, Medicare Advantage, and Medicaid managed care plans. Navigating Aetna's specific medical necessity criteria and administrative processes is paramount for successful authorization.

Aetna's Prior Authorization Channels for Specialty Medications

Aetna leverages multiple channels for prior authorization submissions, which vary by benefit category. For medical benefit specialty drugs like some biologics, requests often route through the Availity provider portal. Aetna also supports X12 278 transactions via clearinghouses for medical benefit precertification. Pharmacy benefit specialty medications are administered through CVS Caremark, accepting ePA via CoverMyMeds or Surescripts for retail, and CVS Caremark's direct portal for mail-order.

Key Considerations for Tezspire Medical Necessity with Aetna

  • Aetna's Clinical Policy Bulletins (CPBs) are the primary source for medical necessity criteria.
  • Documentation must support the specific indications, patient history, and prior treatment failures outlined in the relevant CPB.
  • Review the CPB for any step therapy requirements, which are published within the policy itself.
  • Verify whether the CPB references internally developed criteria or external sources (e.g., NCCN).
  • Ensure all required diagnostic test results and clinical notes are included with the submission.

Navigating Aetna's Turnaround Times and Appeal Process

Prior authorization turnaround times for Aetna are influenced by state-mandated minimums and NCQA Utilization Management accreditation standards. For Medicare Advantage and Medicaid managed care lines, CMS-0057-F mandates 72-hour standard and 24-hour expedited decisions. Should a Tezspire PA be denied, Aetna's appeal pathway typically includes reconsideration, peer-to-peer review, and formal appeal processes, with specific timely-filing windows.

Common Denial Reasons for Tezspire with Aetna

  • Lack of documented medical necessity or insufficient clinical criteria met.
  • Failure to demonstrate required preceding therapies (step therapy).
  • Incomplete or missing supporting clinical documentation.
  • Off-label use without sufficient compendium support.
  • Benefit exclusion or site-of-service mismatch.

Streamlining Aetna Tezspire PA with Klivira

Klivira's platform automates the intricate Aetna Tezspire prior authorization workflow by integrating directly with EMRs and payer portals. Our solution reduces manual data entry, proactively identifies missing documentation, and intelligently routes requests through the correct Aetna submission channels, whether Availity, X12 278, or ePA partners. This enhances efficiency and improves decision-making timelines.

Frequently asked questions

How do I submit Aetna Tezspire prior authorization requests?

For medical benefit requests, submissions are primarily handled through the Availity provider portal, or via X12 278 transactions. If Tezspire is covered under the pharmacy benefit, requests route through CVS Caremark, utilizing ePA partners like CoverMyMeds or Surescripts, or CVS Caremark's direct portal.

Where can I find Aetna's medical necessity criteria for Tezspire?

Aetna publishes its medical necessity criteria in its Clinical Policy Bulletins (CPBs), which are publicly accessible in the Aetna CPB library. You should reference the specific CPB number and review date applicable to Tezspire to understand the current requirements.

Does Aetna require step therapy for Tezspire?

Aetna may require step therapy for Tezspire, as these protocols are typically outlined within the relevant Clinical Policy Bulletins (CPBs). It is crucial to review the specific CPB for Tezspire to understand any preceding therapy requirements.

What are common reasons for Tezspire prior authorization denials by Aetna?

Common denial reasons include insufficient documentation to support medical necessity, failure to meet step therapy requirements, off-label use without compendium support, or missing clinical information. Denials are often communicated via X12 835/277 transactions or portal status updates.

What is the appeal process for a denied Aetna Tezspire PA?

If a Tezspire prior authorization is denied by Aetna, you can typically initiate an appeal. The process usually involves reconsideration, a peer-to-peer review option, and a formal appeal. Expedited appeal pathways exist for urgent care needs, and timely-filing windows vary by line of business and state.

Is Tezspire covered under Aetna's medical or pharmacy benefit?

The benefit assignment for specialty injectables and infusions like Tezspire can vary by Aetna plan and therapeutic category. Providers must verify the current Aetna specialty-drug list or formulary to confirm whether Tezspire falls under the medical or pharmacy benefit for a specific patient's plan.

Related coverage

Other tezspire prior authorization by payer

Other tezspire prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo